Management of
regulated substances
Diagnosis and operating model
Context & objectives
The CSO of a big group, responsible for the compliance to European regulations on chemicals, is facing a lack of visibility on major risks from its BUs (ban of use, site closure, export blockage, …)
To mitigate them, the client has launched a project to implement a new operating model:
- Risk-based
- With a reinforced governance
- Developing group-wide synergies
In 3 months, STEP performs a diagnosis covering:
- x00M€+ of yearly activities
- x00+ technical topics open
- x00+ contributors from all functions: engineering, manufacturing, programmes, services and support, …
And lays the foundations for a group operating model
- Based on 11 standards, built from the success of our previous experiences
- Adapted through a collective approach (2-days seminar, workshops with the operational teams)
*chromates for surface treatment, primers, PFAS, …
Results
Diagnostic performed on the 6 BUs within the group
- x00+ persons interviewed: engineering, procurement, programmes, industry, EHS, public affairs, aftermarket, …
- Deadlines met thanks to a 11-standards analysis grid capitalising on the success from previous missions
- Project portfolio analysis to identify disruption risks (late substitution, supplier exit, …)
- Identification of shortfalls of current activities
- Identification of potential synergies between BUs
New operating model based on:
- “Single Heat Matrix”: to escalate the risks, the priorities, build actions plans with group support
- “Single Source of Truth” based on all parts attributes (substances, processes, suppliers, …)
- A robust governance at all levels (group and BUs) with intermediary decision making (technical topics, supply chain, …)
- Concrete pilot cases for the implementation of synergies (common developments, central functions, …)
Validation meeting with the client (ExCom)
Discover other mission references
Explore our expertise through our greatest success stories.
